Investment Q&A

Q: Any reason for the big price jump in recent two days ? Thanks a lot.

Q: Any reason for the large increase today? I cannot find any news on the stock.

Q: WHAT are you evaluating this company

Q: If you had to choose between Topicus and Lumine for a 5 year investment which one would you pick and why? Also, what are good entry prices for both?
Thanks

Q: Hi guys,

I am looking for your top 3 picks on Canadian markets for dividend income and growth with the emphasis being on dividend income.

Which 3 would they be and why?

Thanks

Sheldon

Q: What is your opinion about the quarterly result of the company? I have a very small position and thinking of holding it.

Q: RESP with 5 years until first withdrawal. Currently only holding is VEQT and approx 30% cash. Looking for some stable compounder companies to sweeten the total return. Please suggest 8 ideas. Thank you

Q: How much higher will it go.
Shall I buy more shares
Thanks

Q: Hi, Constellation's offer to buy 100% of EROAD shares (17.8% already acquired in open market), I thought, should be good news for the stock, as it seems to be a decent size acquisition ( $130 mln ? ). But stock has reacted negatively, over yesterday and today. Any thoughts ? Thanks

Q: Hello,

TD believes the following on BN

After subtracting the market value of BN's stakes in BAM/BEP/BIP, the stock is ascribing negative value to the stake in BBU (~$1.75/share), real-estate (~$20.00/share), insurance (~$2.50/share), and carried interest (~$3.60/share). BN's ~$4bln of annual FCF provides considerable firepower to address the discount, although share buybacks must be weighed against the prospect of growing the franchise. We believe that BN's conviction in the intrinsic value of its stock price is evidenced by ~$750mm of TTM share repurchases and ~ $100mm of share purchases in the open market by the senior executive team.

Couple questions
1. This is the first time I have seen the value of BN being just reflected as just BIP,BEP, and BAM. Would you agree with this.

2. If you agree, isn’t it extremely compelling to get BBU, Reinsurance, oaktree, and property for free?

3. Would you agree with the $61 USD target or 90% upside?

Thank you!

Q: Hi, these are my two stocks that are down the most . I think I will keep GSY through this downturn as I have more confidence in it during rough times? Could you talk about TVE and reasons why I should keep it , sell to half position or just sell for tax loss. We seem to be swimming against the current with government and environmentalists with oil and gas companies. Is it worth keeping at least into the new year when these companies seem to do better?
Thanks

Q: income vs growth stocks
can you please give me a list of your top favourite 10 can GROWTH stocks at the moment
thank you

Q: With the rush to electrify economies, and reduce reliance on fossil fuels, many Co.'s will experience strong growth over the next several years. Can you provide a list of 6-8 Co.'s with strong fundamentals, that trade in Canada, from various affected sectors that you feel stand to benefit by this coming move to electrification. Please rank them from best growth prospects to least. Thank you and please take as many credits as required. ...Will

Q: I noticed in the votes for directors the CEO did rather poorly compared to the other directors. There is generally a reason for these types of results. Perhaps you could let us know what is happening with the company and its management.
Thanks

Q: Hello,

TD believes that BN is only pricing in BIP, BEP and BAM and ascribing no value to BBU, oaktree, insurance and the real estate.

Do you agree? If so, this must be a deal of a century?

TD- After subtracting the market value of BN's stakes in BAM/BEP/BIP, the stock is ascribing negative value to the stake in BBU (~$1.75/share), real-estate (~$20.00/share), insurance (~$2.50/share), and carried interest (~$3.60/share). BN's ~$4bln of annual FCF provides considerable firepower to address the discount, although share buybacks must be weighed against the prospect of growing the franchise. We believe that BN's conviction in the intrinsic value of its stock price is evidenced by ~$750mm of TTM share repurchases and ~ $100mm of share purchases in the open market by the senior executive team.

Q: Peter; Doesn’t it yield about 5.4%? Rod

Q: 1 yr H $38.99,current price $34.51, p/p $43.63 many moons ago. Is this a opportunity to add? and what is a good entry price? Txs for U usual great services & views

Q: Thinking of adding one of these to my TFSA. Which offers more growth and what would be a fair entry price?
Thank you for your steady support through these trying times.
Donna

Q: Hi Peter,

As a subscriber of the service since 2017 (despite being urged to join at least 2 to 3 years earlier) I am very grateful for the information and education that 5i has provided to me. I have used the balanced portfolio for my road map and couldn't be happier. I was wondering if you would't mind humoring me, and sharing what you view to be the three best selections you have made in that portfolio, the three worst, and the three you wish you had made, dating back to the inception in 2013. A small explantion why would be appreciated. This being Friday, that should give you the weekend to reminisce. Take care and have a great weekend to all of the staff at 5i.

Q: Trying to decide between Topicus and Lumine for a long-term growth portfolio here.
I am digging into both, and finding that Lumine gets around a third of revenue from an acquisition they made called Wideorbit. Wideorbit gets almost all of its revenue from ad selling into radio stations, local TV and National TV networks.
I guess I am worried about how this business model can work long term (my teenagers never watch traditional TV or listen to radio, and cord cutting is quite prevalent apparently). Does this high percentage of revenue worry you in terms of Lumine going forward? Thanks